04/17/2025 3:05 PM | Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2025 4:14 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form PRE 14A | |
04/10/2025 5:00 AM | ASTRAZENECA PLC (Filed by) ASTRAZENECA PLC (Filed by) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/01/2025 8:04 PM | Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 8:07 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 8:09 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Fry Simon Jeremy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 8:13 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 4:23 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2025 3:54 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/10/2025 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
03/06/2025 7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CDTTW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
02/20/2025 3:32 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Nirland Ltd (Filed by)
| Form SCHEDULE 13G/A | |
02/19/2025 8:00 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
02/12/2025 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
02/11/2025 7:00 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2025 4:19 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2025 7:58 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
02/05/2025 4:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/23/2025 7:15 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/21/2025 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Nirland Ltd (Filed by)
| Form SCHEDULE 13G | |
01/15/2025 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
12/20/2024 4:05 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Fry Simon Jeremy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/20/2024 4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Fry Simon Jeremy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 4:06 PM | Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2024 4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/16/2024 4:01 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
12/09/2024 7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form DEF 14A | |
12/08/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
12/09/2024 5:11 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
11/26/2024 4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form PRE 14A | |
11/25/2024 4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/25/2024 3:53 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:22 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 10-Q/A | |
11/14/2024 4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 10-Q/A | |
11/14/2024 4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 5:01 AM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) St George Street Capital (Filed by)
| Form SC 13G/A | |
11/04/2024 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
Trump and Musk fight back (Ad) Is there more to the Musk–Trump relationship than meets the eye?
Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance.
At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge. Click here to see why Jeff believes this is the biggest stock story of the year — and which companie |
11/04/2024 4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
11/03/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
11/01/2024 4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form DEFA14A | |
11/01/2024 3:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form DEF 14A | |
10/28/2024 4:16 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form DEFA14A | |
10/28/2024 4:17 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form ARS | |
10/24/2024 5:12 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/18/2024 3:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/16/2024 4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form PRE 14A | |
10/15/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2024 5:01 AM | ASTRAZENECA PLC (Filed by) ASTRAZENECA PLC (Filed by) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject)
| Form SC 13G | |
10/07/2024 6:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/07/2024 6:38 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Dovet Ltd (Reporting) Nirland Ltd (Reporting) Rowland Master Trust (Reporting) Stockton Ltd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 4:02 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Dovet Ltd (Reporting) Nirland Ltd (Reporting) Rowland Master Trust (Reporting) Stockton Ltd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:59 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Corvus Capital Ltd. (Filed by)
| Form SC 13D/A | |
09/19/2024 4:01 PM | Algo Holdings, Inc. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Corvus Capital Ltd. (Reporting) Regan Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 3:41 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
09/16/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
09/06/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/04/2024 3:44 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
08/19/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
08/16/2024 3:59 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 4:53 PM | Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:56 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
05/14/2024 3:05 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Intelmed LLC (Reporting) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Tapolczay David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |